Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Jesus M Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W Fraser Symmans, Charles Perou, Lisa A Carey, Ann H Partridge, Hope S Rugo
NPJ Breast Cancer 10(1) 75
摘要
摘要
Association of stromal tumor-infiltrating lymphocytes (sTILs) with survival outcomes among patients with metastatic breast cancer (MBC) remains unclear. The primary objective was to evaluate the association of sTILs with progression-free survival in randomized phase III trial CALGB 40502. sTILs were associated with progression-free and overall survival in chemotherapy-treated MBC when controlling for treatment arm; however, this effect did not remain significant after additional adjustment for hormone receptor status. CALGB is now part of the Alliance for Clinical Trials in Oncology. Trial Registration: ClinicalTrials.gov: NCT00785291.
KM 提取结果
0 个 Figure · 0 个 KM 面板